UK markets closed

MediWound Ltd. (MDWD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.650.00 (0.00%)
As of 11:00AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 177.02M
Enterprise value 141.83M
Trailing P/E 27.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.00
Price/book (mrq)5.60
Enterprise value/revenue 7.59
Enterprise value/EBITDA -29.54

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 377.74%
S&P500 52-week change 322.38%
52-week high 319.86
52-week low 37.10
50-day moving average 315.89
200-day moving average 311.32

Share statistics

Avg vol (3-month) 378.86k
Avg vol (10-day) 369.06k
Shares outstanding 59.49M
Implied shares outstanding 69.49M
Float 85.02M
% held by insiders 125.73%
% held by institutions 134.51%
Shares short (15 Apr 2024) 4171.63k
Short ratio (15 Apr 2024) 41.85
Short % of float (15 Apr 2024) 42.16%
Short % of shares outstanding (15 Apr 2024) 41.81%
Shares short (prior month 15 Mar 2024) 4153.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 320 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -35.94%
Operating margin (ttm)-76.90%

Management effectiveness

Return on assets (ttm)-16.64%
Return on equity (ttm)-31.60%

Income statement

Revenue (ttm)18.69M
Revenue per share (ttm)2.07
Quarterly revenue growth (yoy)-54.10%
Gross profit (ttm)N/A
EBITDA -14.76M
Net income avi to common (ttm)-6.72M
Diluted EPS (ttm)-0.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.54M
Total cash per share (mrq)4.49
Total debt (mrq)6.48M
Total debt/equity (mrq)20.52%
Current ratio (mrq)4.59
Book value per share (mrq)3.43

Cash flow statement

Operating cash flow (ttm)-10.46M
Levered free cash flow (ttm)-10.12M